Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal

SystImmune and Bristol Myers Squibb & Co (NYSE:BMY) announced an exclusive license and collaboration agreement for Sy...

Related Keywords

China ,Bristol Myers ,William Blair ,Bristol Myer ,Abbvie Inc ,Immunogen Inc ,Bristol Myers Squibb ,Bristol Myers Squibb Co ,Seagen Inc ,Pfizer ,Pfizer Inc ,Nasdaq ,Mainland China ,Myers Squibb ,Market Perform ,Orum Therapeutic ,